title: Potential uses of probiotics in clinical practice.
abstract: Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. There is now mounting evidence that selected probiotic strains can provide health benefits to their human hosts. Numerous clinical trials show that certain strains can improve the outcome of intestinal infections by reducing the duration of diarrhea. Further investigations have shown benefits in reducing the recurrence of urogenital infections in women, while promising studies in cancer and allergies require research into the mechanisms of activity for particular strains and better-designed trials. At present, only a small percentage of physicians either know of probiotics or understand their potential applicability to patient care. Thus, probiotics are not yet part of the clinical arsenal for prevention and treatment of disease or maintenance of health. The establishment of accepted standards and guidelines, proposed by the Food and Agriculture Organization of the United Nations and the World Health Organization, represents a key step in ensuring that reliable products with suitable, informative health claims become available. Based upon the evidence to date, future advances with single- and multiple-strain therapies are on the horizon for the management of a number of debilitating and even fatal conditions.
authors.affiliation: Canadian Research and Development Centre for Probiotics, The Lawson Health Research Institute, London, Ontario N6A 4V2, Canada. gregor@uwo.ca
authors.forename: Gregor
authors.initials: G
authors.lastname: Reid
authors.forename: Jana
authors.initials: J
authors.lastname: Jass
authors.forename: M Tom
authors.initials: MT
authors.lastname: Sebulsky
authors.forename: John K
authors.initials: JK
authors.lastname: McCormick
mesh_terms: D000328:Adult; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000209:etiology / Q000628:therapy; D005260:Female; D005767:Gastrointestinal Diseases / Q000209:etiology / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D007223:Infant; D007239:Infections / Q000209:etiology / Q000628:therapy*; D007778:Lactobacillus; D019936:Probiotics / Q000627:therapeutic use*